Bayer Says One A Day Selenium Prostate Cancer Claims Are In Fair Play
This article was originally published in The Tan Sheet
Executive Summary
Bayer asserts the prostate cancer risk reduction claims for its One A Day Men's multivitamin supplements are backed by an FDA-approved qualified health claim for selenium
You may also be interested in...
One A Day Marketing Claims Spark Another CSPI-Bayer Face Off
The Center for Science in the Public Interest threatens to sue if Bayer HealthCare does not discontinue claims that One A Day multivitamins “support” breast, heart, eye and bone health. CSPI argues the problem is rooted in linking legitimate claims to scientific research in a way that implies disease claims.
One A Day Marketing Claims Spark Another CSPI-Bayer Face Off
The Center for Science in the Public Interest threatens to sue if Bayer HealthCare does not discontinue claims that One A Day multivitamins “support” breast, heart, eye and bone health. CSPI argues the problem is rooted in linking legitimate claims to scientific research in a way that implies disease claims.
FDA Looms Large As Bayer Surrenders One A Day Selenium Prostate Claims
Bayer seems to be heeding FDA's message that the administration will not tolerate playing fast and loose with health claims